Results 91 to 100 of about 27,707 (119)

Off-label GLP-1 receptor agonist and tirzepatide use for weight loss: patient safety and regulatory oversight. [PDF]

Ann Med Surg (Lond)
Maqsood A, Khan AR, Aaqil SI, Cheema AAA, Ali M, Jacob J, Naeem M, Kamal Siddiqi A.   +7 more
europepmc   +1 more source

Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications. [PDF]

Curr Obes Rep
Lee J, You JH, Park HJ, Roh JL, Paek SH.
europepmc   +1 more source

Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity. [PDF]

JCI Insight
Son AJ, Rapp E, Wiezorek A, Leung MG, Banerjee RR, Leung TH.   +5 more
europepmc   +1 more source

The GLP-1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap. [PDF]

Int J Dermatol
Awadalla R, Davies D.
europepmc   +1 more source

Association of GLP-1 Receptor Agonist Use with Hypersomnolence: A Real-world Cohort Analysis. [PDF]

J Diabetes Metab Disord
Kamel-Abusalha L, Afifi AM, Dawoud A, Hayath Z, Bouso MF, Aguillon A, Assaly R.   +6 more
europepmc   +1 more source

Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. <i>Children</i> 2025, <i>12</i>, 1427. [PDF]

Children (Basel)
Improda N, Ballarin G.
europepmc   +1 more source

First-in-Human Study of a Long-Acting GLP-1 Receptor Agonist (TE-8105) in Overweight or Obese Adults Without Type 2 Diabetes Mellitus. [PDF]

J Clin Pharmacol
Chuang YS, Wright JD, Wong MT, Paneliya KJ, Yang WS, Chu HM, Chang TW, Polasek TM.   +7 more
europepmc   +1 more source

Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review. [PDF]

Front Clin Diabetes Healthc
Jędrasek A, Lisowska K, Czupryniak L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

Cell Metabolism, 2022
Libbey O'Farrell, Matthew M Abernathy, Ruth E Gimeno   +2 more
exaly